Back to Search
Start Over
Male Reproductive Endocrine Disorders.
- Source :
-
Primary care [Prim Care] 2024 Sep; Vol. 51 (3), pp. 455-466. Date of Electronic Publication: 2024 May 23. - Publication Year :
- 2024
-
Abstract
- The endocrine system intricately regulates male sexual development and health which influences masculinization, sexual libido, muscle mass, bone density, and overall vitality. Disorders in the hypothalamic-pituitary-gonadal axis can lead to hypogonadism, gynecomastia, sexual dysfunction, and infertility. Testosterone replacement therapy can be considered for symptomatic hypogonadism but poses risks for azoospermia and polycythemia, along with uncertain impact on cardiovascular disease. Gynecomastia results from a high estrogen-to-androgen ratio, mostly from either excess estrogen or decreased androgens. Sexual dysfunction is more commonly secondary to psychological or metabolic disorders; consider workups to rule out endocrine etiologies including hypogonadism if indicated.<br />Competing Interests: Disclosure The authors have nothing to disclose.<br /> (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Subjects :
- Humans
Male
Sexual Dysfunction, Physiological therapy
Sexual Dysfunction, Physiological diagnosis
Endocrine System Diseases diagnosis
Endocrine System Diseases complications
Testosterone
Hormone Replacement Therapy methods
Primary Health Care
Infertility, Male etiology
Infertility, Male therapy
Infertility, Male physiopathology
Infertility, Male diagnosis
Hypogonadism diagnosis
Gynecomastia diagnosis
Gynecomastia therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1558-299X
- Volume :
- 51
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Primary care
- Publication Type :
- Academic Journal
- Accession number :
- 39067971
- Full Text :
- https://doi.org/10.1016/j.pop.2024.04.003